What Are Prednisone's Long-Term Side Effects in EGPA?

Prednisone is a fast-acting, life-saving medication used to rapidly control the severe inflammation caused by Eosinophilic Granulomatosis with Polyangiitis (EGPA) ^[1]. However, long-term use can cause significant and serious side effects, including weight gain, bone density loss, elevated blood sugar, and cataracts ^[2][3]. Because of these risks, a key goal in EGPA management is to safely lower your prednisone dose to the lowest effective amount ^[4].

For severe, organ- or life-threatening EGPA (such as severe heart, kidney, or nerve involvement), high-dose glucocorticoids are initially required, often combined with powerful immunosuppressants like rituximab or cyclophosphamide ^[5]. Once the disease is controlled, or for patients with non-severe or relapsing EGPA, “steroid-sparing” medications like the biologic mepolizumab may be used to help reduce the daily prednisone requirement ^[1].

Why is it so hard to stop taking prednisone?

Many people find the physical and emotional effects of prednisone difficult and wonder how long they will have to take it. Completely stopping steroids can be challenging, and some people may require a low maintenance dose long-term. Studies show that many patients struggle to discontinue glucocorticoids entirely, often because of lingering asthma and severe sinus or ear, nose, and throat (ENT) symptoms ^[6][7].

Additionally, prolonged prednisone use causes your body to suppress its own production of the natural stress hormone cortisol ^[8]. This condition is known as adrenal insufficiency. If you stop taking prednisone abruptly, or if you become severely ill and your body cannot produce enough cortisol, it can lead to a life-threatening adrenal crisis ^[8][9].

Adrenal crisis is a medical emergency. Seek urgent medical care if you experience severe weakness, repeated vomiting or diarrhea, fainting, marked dizziness, or confusion. Never stop or change your prednisone dose without your clinician’s guidance. Ask your doctor for a “sick day” plan (which may include “stress dosing” or taking extra steroids when you are ill, injured, or having surgery) and always carry a medical alert card identifying that you take daily steroids ^[9].

Common Long-Term Risks and How They Are Managed

When prednisone is needed long-term, your care team should actively monitor and manage the associated risks ^[2].

• Bone Density Loss (Osteoporosis): Prednisone weakens bones and increases fracture risk ^[3].
  • Management: Your doctor should assess your fracture risk using a DXA scan (a bone density test) ^[3]. Management includes weight-bearing exercise, adequate dietary calcium, and fall prevention. Depending on your risk, you may be prescribed vitamin D and calcium supplements or a bone-protecting medication like a bisphosphonate ^[3].
• Metabolic Changes: Steroids change how your body processes sugar and stores fat, which can lead to weight gain and steroid-induced diabetes ^[2].
  • Management: Your care team should monitor your blood pressure, weight, and blood sugar ^[2]. Note that fasting glucose or A1c alone might miss afternoon blood sugar spikes caused by morning prednisone, so post-meal monitoring is sometimes necessary.
• Heart Health Risks: Cumulative steroid exposure can increase the risk of plaque buildup in the arteries (atherosclerosis) ^[10].
  • Management: Regular monitoring of cholesterol and blood pressure, along with lifestyle adjustments, is crucial to protect your heart ^[10].
• Increased Risk of Infection: Prednisone suppresses your immune system, making you more vulnerable to serious or recurrent infections ^[11]. The risk is higher if you take prednisone alongside other immunosuppressants.
  • Management: Stay up to date on recommended non-live vaccines (like flu and pneumococcal vaccines). Do not receive “live” vaccines without explicit clearance from your specialist. Call your doctor promptly for fevers or other signs of infection ^[12].
• Eye Complications: Long-term use increases the risk of cataracts and glaucoma ^[2].
  • Management: Schedule baseline and periodic comprehensive eye exams. Seek urgent eye care for new vision loss, eye pain, or seeing halos.

The Role of Steroid-Sparing Medications

To minimize these long-term risks, EGPA guidelines support individualized steroid reduction once your vasculitis is stable ^[1]. Mepolizumab is an add-on biologic medication approved in many countries for non-severe or relapsing EGPA ^[1]. It works by targeting eosinophils, the white blood cells responsible for much of the inflammation in EGPA.

In the pivotal MIRRA clinical trial for relapsing or refractory EGPA, 44% of patients receiving mepolizumab were able to reduce their average prednisone dose to 4 mg a day or less, compared to only 7% of those on placebo ^[13][14]. In long-term extension studies, some selected participants (approximately 26% to 28%) were able to completely discontinue oral glucocorticoids under strict protocol monitoring ^[15][16].

While these statistics are encouraging, mepolizumab does not work for everyone, and it is not an immediate rescue therapy for an EGPA flare. Even if a completely steroid-free remission is not achievable, lowering your dose can still help reduce your long-term health risks ^[4].

Warning Signs: Relapse vs. Withdrawal

It can be difficult to tell the difference between steroid withdrawal symptoms, uncontrolled asthma/sinus disease, and a true EGPA relapse. Tapering prednisone when vasculitis is still active is dangerous. Seek prompt medical assessment if you develop new or worsening shortness of breath, chest pain, coughing up blood, new weakness or numbness, blood in your urine, or rapidly worsening skin rashes ^[17]. Do not simply increase or decrease your prednisone dose on your own.